Active Ingredient: EFAVIRENZ; EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE
Proprietary Name: EFAVIRENZ, EMTRICITABINE, AND TENOFOVIR DISOPROXIL FUMARATE
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 600MG;200MG;300MG
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A091215
Product Number: 001
Approval Date: Nov 9, 2018
Applicant Holder Full Name: TEVA PHARMACEUTICALS USA
Marketing Status:
Prescription
Patent and Exclusivity Information
